Victory Capital Management Inc Xenon Pharmaceuticals Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$34.84 - $43.54 $755,679 - $944,382	-21,690 Reduced 76.94%	6,500 $250,000
Q1 2023 May 02, 2023	BUY	$33.46 - $40.35 $943,237 - $1.14 Million	28,190 New	28,190 $1.01 Million
Q3 2022 Nov 02, 2022	SELL	$30.79 - $39.82 $28,018 - $36,236	-910 Reduced 6.93%	12,228 $441,000
Q2 2022 Aug 01, 2022	SELL	$25.44 - $35.16 $28,645 - $39,590	-1,126 Reduced 7.89%	13,138 $400,000
Q1 2022 May 04, 2022	BUY	$25.09 - $33.13 $168,579 - $222,600	6,719 Added 89.05%	14,264 $403,000
Q4 2021 Feb 07, 2022	BUY	$15.6 - $35.4 $117,702 - $267,093	7,545 New	7,545 $236,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.